Intellia Therapeutics
Intellia Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the research and clinical development of gene editing therapies for patients with genetically-based diseases.
- Founded
- 2014
- Headcount
- 364
- Open roles
- 0
- Last raised
- Post Ipo Equity · $180M
- 01Engineering interview process at Intellia TherapeuticsLocked
- 02Tech stack & infrastructure choicesLocked
- 03Culture & day-to-day work styleLocked
- 04Why join now vs. 6 months from nowLocked
- 05Hiring focus & open headcount by teamLocked
- 06Comp philosophy and band contextLocked
7-day free trial · $25/mo · cancel anytime